Improving care for patients with Parkinson’s Disease

The challenge

Healthcare management for patients with Parkinson’s disease (PD) is currently fragmented and inefficient.[1] The severity of this problem is significant both at EU and global levels. PD is a substantial burden for patients, caregivers and society, affecting 10 million patients worldwide, with 1.2 million in Europe alone.[2] It is the fastest-growing neurodegenerative disease, leading to overall cost of 48 billion euros worldwide, with cases projected to double by 2040.[3]

The disease is characterised by various motor and non-motor symptoms, with gait and mobility impairments which reduce patients’ independence and quality of life (QoL). Since there is no cure for PD, addressing gait and mobility impairments is the key to better QoL of patients.

In the treatment of gait and mobility impairments, patients with PD experience a lack of coordinated and interdisciplinary care, representing the major problem for them. Diagnostic and therapeutic procedures are often unsynchronised, resulting in uncertain and delayed treatment. Timely access to healthcare services is frequently lacking. Moreover, patients are not adequately motivated and empowered to manage their disease, e.g. by regular exercises. Consequently, patients endure prolonged suffering, develop associated comorbidities, and incur substantial costs.

The burden extends not only to patients with Parkinson’s disease, but also to the families and caregivers of patients, who face overwhelming responsibilities in providing care and acting as care managers. Neurologists and other healthcare professionals (HCPs) involved in PD management also encounter numerous challenges. They frequently rely on incomplete and unreliable patient-reported information, as well as missing reports from other involved HCPs, resulting in time-consuming trial-and-error medication adjustments. Moreover, limited collaboration with other HCPs hinders their ability to share findings and treatment plans effectively. These challenges are exacerbated by the lack of appropriate IT infrastructure which further impedes the sharing of vital information.

The economic consequences of the unmet need in treating gait and mobility impairment are substantial. Falls among PD patients alone cost approximately €2.9 billion per year in industrialised nations.[4] Hospitalisations resulting from PD related gait and mobility problems contribute an additional cost of €3.2 billion per year and the overall cost of PD healthcare in Europe amounts to approximately €14 billion per year.[5]

Fragmented care, limited interdisciplinary collaboration, insufficient patient motivation, and delayed access to healthcare services have significant impact on patients, their families, and HCPs, while incurring substantial economic costs both within the EU and globally. PDnetGO provides a solution for these issues by improving the gait and mobility management of PD, integrating it into healthcare procedures, and enhancing the well-being of PD patients.

The solution

PDnetGo combines the well-established digital health solution ’ParkinsonGo’ provided by Portabiles HealthCare Technologies (PHCT) with a managed care service platform, inspired by integrated care concepts like ParkinsonNet.

ParkinsonGo, which was co-funded by the EIT Health DiGinnovation programme, is a class 1 CE marked medical device under MDR, and includes a smartphone app and wearable sensors for assessing gait and mobility. It provides diagnostic and therapy decision support to neurologists by analysing symptom patterns derived from gait assessments, PROMS, and PREMS (patient reported outcome/experience measures). Patients benefit from personalised interventions, including customised physiotherapeutic exercises, advice, and educational resources facilitated by ParkinsonGo’s AI algorithms.

PDnetGo is a unique telemedical managed care solution that follows a Value-Based Healthcare (VBHC) approach to enhance collaboration between HCPs and patients in the treatment of gait and mobility impairments. The central goal of PDnetGO is to promote long-term mobility and activity of patients and enhance their quality of life, alleviating the burden on family caregivers, optimising the overall care process and reducing costs.

Expected impact

The aim of PDnetGo is to reduce hospital cost and fall injuries in Parkinson’s patients by 30% (with associated cost savings of up to 2 billion euros per year in industry nations), while improving quality of life of patients and care givers significantly.

External Partners
  • Portabiles HealthCare Technologies (Activity Leader)
  • Contractual Working Group Hessen
  • Radboud University Medical Centre
  • Phillips Hospital Marburg
  • Asociación Parkinson Madrid
  • OptiMedis AG
  • Hospices Civils de Lyon
References

[1] Dorsey et al.,Teleneurology and mobile technologies: the future of neurological care, Nature Reviews | Neurology; May 2018

[2] The Lewin Group, Inc., The Economic Burden of Parkinson’s disease, 2019

[3] The Lewin Group, Inc., The Economic Burden of Parkinson’s disease, 2019

[4] Hoffmann et al., The Costs of Fall-Related Injuries among Older Adults; Health Services Research; October 2017

[5] Klein et al.; Admission of Parkinsonian patients to a neurological ward in a community hospital, Movement Disorders; Sept. 2009

Ralph Steidl
| CEO | Portabiles HealthCare Technologies
Contact